Data table |
ID |
GENE_NAME |
COORDINATE |
GB_LIST |
SP_LIST |
REG_IN_CANCER |
%HOMOLOGY |
HOMOLOGY |
TISSUE_CLASSIFICATION |
4 |
c-myc proto-oncogene |
F3d |
V00568 |
P01106, P01107 |
up-regulated in MCF7-ErbB2 |
|
known |
Additional Cancer Genes (non-differentially expressed) |
14 |
p53-binding mouse double minute 2 homolog (MDM2) |
F1b |
Z12020, M92424 |
Q00987, Q13226 |
|
|
|
Additional Cancer Genes (non-differentially expressed) |
15 |
platelet-derived growth factor B subunit precursor (PDGFB; PDGF2); bacaplermin; c-sis |
F2a |
X02811, X02744, M12783, M16288 |
P01127, P78431 |
|
|
|
Additional Cancer Genes (non-differentially expressed) |
16 |
liver glyceraldehyde 3-phosphate dehydrogenase (GAPDH; G3PDH) |
G12 |
X01677 |
P04406 |
|
|
known |
|
38 |
p53 cellular tumor antigen |
F1d |
M14694, M14695 |
P04637 |
|
|
|
Additional Cancer Genes (non-differentially expressed) |
49 |
cytoplasmic beta-actin (ACTB) |
G19 |
X00351 |
P02570, Q11211, P99021, Q64316, P70514 |
|
|
known |
|
153 |
c-jun proto-oncogene; avian sarcoma virus 17 oncogene homolog; transcription factor AP-1 |
F1j |
J04111 |
P05412 |
|
|
|
Additional Cancer Genes (non-differentially expressed) |
161 |
erbB2 proto-oncogene; neu proto-oncogene; HER2 |
F1m |
M95667, M11730 |
P04626, Q14256 |
up-regulated in MCF7-ErbB2 |
|
known |
Additional Cancer Genes (non-differentially expressed) |
196 |
platelet-derived growth factor receptor alpha precursor (PDGFR-alpha; PDGFRA); CD140A antigen |
F2n |
M21574 |
P16234 |
up-regulated in IMR90 |
|
known |
Additional Cancer Genes (non-differentially expressed) |
254 |
vascular endothelial growth factor receptor 1 (VEGFR1); fms-related tyrosine kinase 1 (FLT1); soluble VEGFR; soluble FLT (SFLT) |
F1n |
X51602, U01134 |
P17948, P16057, Q12954 |
|
|
|
Additional Cancer Genes (non-differentially expressed) |
330 |
transforming growth factor beta 3 (TGF-beta3; TGFB3) |
F1g |
J03241 |
P10600 |
|
|
|
Additional Cancer Genes (non-differentially expressed) |
359 |
nucleoside diphosphate kinase B (NDP kinase B; NDKB); expressed in non-metastatic cells 2 protein (NME2); myc purine-binding transcription factor (PUF); NM23B |
F1h |
L16785, M36981 |
P22392 |
up-regulated in MCF7-ErbB2 |
|
known |
Additional Cancer Genes (non-differentially expressed) |
386 |
mas proto-oncogene |
F2b |
M13150 |
P04201 |
|
|
|
Additional Cancer Genes (non-differentially expressed) |
455 |
colorectal mutant cancer protein (MCC) |
F1f |
M62397 |
P23508 |
|
|
|
Additional Cancer Genes (non-differentially expressed) |
458 |
early growth response protein 1 (EGR1); transcription factor ETR103; KROX24; zinc finger protein 225 (ZNF225); AT225 |
F3c |
X52541, M62829 |
P18146 |
up-regulated in MCF7-ErbB2 |
|
known |
Additional Cancer Genes (non-differentially expressed) |
541 |
cyclin-dependent kinase inhibitor 1A (CDKN1A); melanoma differentiation-associated protein 6 (MDA6); CDK-interacting protein 1 (CIP1); WAF1; SDI1 |
F3b |
U09579, L25610 |
P38936 |
up-regulated in MCF7 |
|
known |
Additional Cancer Genes (non-differentially expressed) |
573 |
Wilms' tumor protein (WT33; WT1) |
F1e |
X51630 |
P19544 |
|
|
|
Additional Cancer Genes (non-differentially expressed) |
632 |
cyclin-dependent protein kinase 2 (CDK2); p33 protein kinase |
F2h |
M68520 |
P24941 |
|
|
|
Additional Cancer Genes (non-differentially expressed) |
633 |
cell division cycle 25 homolog A (CDC25A); M-phase inducer phosphatase 1 (MPI1) |
F3a |
M81933 |
P30304 |
|
|
|
Additional Cancer Genes (non-differentially expressed) |
636 |
G2/mitotic-specific cyclin A (CCNA; CCN1) |
F2f |
X51688 |
P20248 |
|
|
|
Additional Cancer Genes (non-differentially expressed) |